CEO Quentin Blackford was paid $11,003,163 in fiscal year 2025, ↑ up 17.8% from fiscal year 2024, the 69th percentile of its disclosed peer group (SEC filing 0001388658-26-000030 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$11,003,163 ↑ Quentin Blackford total, FY2025 | 69th CEO pay percentile vs peers | 96.6:1 CEO-to-median pay ratio | 95.72% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
IRTC's next annual pay disclosure, estimated April 18, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Quentin Blackford | $700,003 | $0 | $8,919,457 | $0 | $1,350,000 | $0 | $33,703 | $11,003,163 |
| President and Chief Executive Officer | ||||||||
| Chad Patterson | 495,962 | 0 | 2,800,227 | 0 | 750,000 | 0 | 33,448 | 4,079,637 |
| Chief Commercial Officer | ||||||||
| Minang Turakhia | 478,587 | 0 | 2,592,718 | 0 | 523,200 | 0 | 31,298 | 3,625,803 |
| Chief Medical and Scientific Officer, and EVP, Advanced Technologies | ||||||||
| Patrick Murphy | 468,645 | 0 | 2,074,174 | 0 | 486,500 | 0 | 32,198 | 3,061,517 |
| Chief Business Officer and Chief Legal Officer | ||||||||
| Daniel Wilson | 446,162 | 0 | 2,074,174 | 0 | 490,500 | 0 | 33,537 | 3,044,373 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Quentin Blackford | $11,003,163 | $9,343,903 | $16,595,149 | ↑ +1,659,260 |
| Chad Patterson | 4,079,637 | 3,643,443 | 5,765,377 | ↑ +436,194 |
| Minang Turakhia | 3,625,803 | 3,318,056 | 5,316,031 | ↑ +307,747 |
| Patrick Murphy | 3,061,517 | 2,997,819 | 5,333,779 | ↑ +63,698 |
| Daniel Wilson | 3,044,373 | 2,538,874 | — | ↑ +505,499 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read iRhythm Holdings, Inc.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper IRTC reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the iRhythm Holdings, Inc. Peer Teardown Report
$11,003,163 Quentin Blackford total, FY2025
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of October 1, 2026 · Source: 0001388658-26-000030 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for IRTC
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order IRTC
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
The list of companies that name IRTC as a peer is temporarily unavailable — recheck shortly.
Get the iRhythm Holdings, Inc. Executive Compensation Report
$1,500
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Abhijit Talwalkar | Chair of the Board | $309,480 |
| Brian Yoor | Independent Director | $271,980 |
| Bruce Bodaken | Independent Director | $269,480 |
| C. Noel Bairey Merz | Independent Director | $254,480 |
| Jason Patten | Independent Director | — |
| Karen Ling | Independent Director | $261,980 |
| Karen McGinnis | Independent Director | $314,753 |
| Kevin O'Boyle | Independent Director | $317,172 |
| Mark Rubash | Former director (through FY2025) | $228,121 |
| Mojdeh Poul | Independent Director | $26,429 |
| Ralph Snyderman | Former director (through FY2025) | $225,540 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Brian Lee Lawrence | Chief Technology Officer | 2026-05-04 | D | 1,014 | $121 | $122,491 | Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-11 | D | 5,312 | 11 | 56,892 | Derivative, Class A Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-11 | D | 290 | 121 | 34,954 | Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-11 | D | 2,293 | 118 | 270,611 | Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-11 | D | 642 | 117 | 75,102 | Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-11 | D | 940 | 116 | 109,091 | Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-11 | D | 1,147 | 119 | 136,672 | Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-11 | A | 5,312 | 11 | 56,892 | Common | Form 4 ↗ |
| Brian Yoor | Director | 2026-05-27 | A | 1,573 | 0 | 0 | Common | Form 4 ↗ |
| Karen Ling | Director | 2026-05-27 | A | 1,573 | 0 | 0 | Common | Form 4 ↗ |
| Bruce Bodaken | Director | 2026-05-27 | A | 1,573 | 0 | 0 | Common | Form 4 ↗ |
| Kevin C. Oboyle | Director | 2026-05-27 | A | 1,573 | 0 | 0 | Common | Form 4 ↗ |
| Karen McGinnis | Director | 2026-05-27 | A | 1,573 | 0 | 0 | Common | Form 4 ↗ |
| Abhijit Talwalkar | Director | 2026-05-27 | A | 1,573 | 0 | 0 | Common | Form 4 ↗ |
| Bairey Merz Cathleen Noel | Director | 2026-05-27 | A | 1,573 | 0 | 0 | Common | Form 4 ↗ |
| Sean Clinton Freeman | EVP, Strategy & Corp Devt | 2026-05-29 | A | 273 | 97 | 26,431 | Common | Form 4 ↗ |
| Minang Turakhia | Chief Med/SCI Ofcr EVP Advtech | 2026-05-29 | A | 137 | 97 | 13,264 | Common | Form 4 ↗ |
| Marc Wade Rosenbaum | Chief Accounting Officer | 2026-05-29 | A | 178 | 97 | 17,233 | Common | Form 4 ↗ |
| Sumi Shrishrimal | EVP, Chief Risk Officer | 2026-05-29 | A | 133 | 97 | 12,876 | Common | Form 4 ↗ |
| Chad Patterson | Chief Comm & Product Officer | 2026-05-29 | A | 177 | 97 | 17,136 | Common | Form 4 ↗ |
| Quentin Blackford | Director | 2026-05-29 | A | 178 | 97 | 17,233 | Common | Form 4 ↗ |
| Sumi Shrishrimal | EVP, Chief Risk Officer | 2026-06-02 | D | 1,716 | 108 | 185,653 | Common | Form 4 ↗ |
| Marc Wade Rosenbaum | Chief Accounting Officer | 2026-06-02 | D | 729 | 108 | 78,870 | Common | Form 4 ↗ |
| Sean Clinton Freeman | EVP, Strategy & Corp Devt | 2026-07-02 | D | 918 | 125 | 114,484 | Common | Form 4 ↗ |
| Minang Turakhia | Chief Med/SCI Ofcr EVP Advtech | 2026-07-02 | D | 1,423 | 125 | 177,462 | Common | Form 4 ↗ |
| Julianne Rodda | EVP, Chief People Officer | 2026-08-03 | D | 2,112 | 122 | 257,919 | Common | Form 4 ↗ |
| Mervin Smith | EVP Strategic Business Ops | 2026-08-03 | D | 617 | 122 | 75,349 | Common | Form 4 ↗ |
| Chad Patterson | Chief Comm & Product Officer | 2026-08-03 | D | 2,712 | 122 | 331,192 | Common | Form 4 ↗ |
| Quentin Blackford | Director | 2026-08-07 | A | 48,534 | 0 | 0 | Common | Form 4 ↗ |
| Minang Turakhia | Chief Med/SCI Ofcr EVP Advtech | 2026-08-07 | A | 13,589 | 0 | 0 | Common | Form 4 ↗ |
| Sumi Shrishrimal | EVP, Chief Risk Officer | 2026-08-07 | A | 9,706 | 0 | 0 | Common | Form 4 ↗ |
| Patrick Murphy | CBO and CLO | 2026-08-07 | A | 13,589 | 0 | 0 | Common | Form 4 ↗ |
| Chad Patterson | Chief Comm & Product Officer | 2026-08-07 | A | 13,589 | 0 | 0 | Common | Form 4 ↗ |
| Patrick Murphy | CBO and CLO | 2026-08-10 | D | 7,093 | 125 | 884,156 | Common | Form 4 ↗ |
| Quentin Blackford | Director | 2026-08-10 | D | 26,859 | 125 | 3,348,012 | Common | Form 4 ↗ |
| Chad Patterson | Chief Comm & Product Officer | 2026-08-10 | D | 7,093 | 125 | 884,170 | Common | Form 4 ↗ |
| Minang Turakhia | Chief Med/SCI Ofcr EVP Advtech | 2026-08-10 | D | 7,093 | 125 | 884,151 | Common | Form 4 ↗ |
| Sumi Shrishrimal | EVP, Chief Risk Officer | 2026-08-10 | D | 5,372 | 125 | 669,641 | Common | Form 4 ↗ |
| Daniel Wilson | Chief Financial Officer | 2026-09-02 | D | 773 | 122 | 94,175 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Chad Patterson | RSU | 2025-02-26 | — | — | 12,118 | — | $1,325,952 |
| Chad Patterson | PSU | 2025-02-26 | 6,059 | 12,118 | — | 24,236 | 1,474,276 |
| Daniel Wilson | RSU | 2025-02-26 | — | — | 8,976 | — | 982,154 |
| Quentin Blackford | PSU | 2025-02-26 | 19,300 | 38,599 | — | 77,198 | 4,695,954 |
| Quentin Blackford | RSU | 2025-02-26 | — | — | 38,599 | — | 4,223,503 |
| Daniel Wilson | PSU | 2025-02-26 | 4,488 | 8,976 | — | 17,952 | 1,092,020 |
| Patrick Murphy | PSU | 2025-02-26 | 4,488 | 8,976 | — | 17,952 | 1,092,020 |
| Patrick Murphy | RSU | 2025-02-26 | — | — | 8,976 | — | 982,154 |
| Minang Turakhia M.S. | PSU | 2025-02-26 | 5,610 | 11,220 | — | 22,440 | 1,365,025 |
| Minang Turakhia M.S. | RSU | 2025-02-26 | — | — | 11,220 | — | 1,227,692 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Chad Patterson | $1,325,952 | $1,474,276 | $0 | 52.6% |
| Daniel Wilson | 982,154 | 1,092,020 | 0 | 52.6% |
| Quentin Blackford | 4,223,503 | 4,695,954 | 0 | 52.6% |
| Patrick Murphy | 982,154 | 1,092,020 | 0 | 52.6% |
| Minang Turakhia M.S. | 1,227,692 | 1,365,025 | 0 | 52.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Quentin Blackford | RSU | 48,534 | — | $8,611,873 |
| Quentin Blackford | RSU | 38,599 | — | 6,849,007 |
| Chad Patterson | RSU | 5,262 | — | 933,689 |
| Quentin Blackford | RSU | 30,938 | — | 5,489,639 |
| Quentin Blackford | RSU | 28,775 | — | 5,105,836 |
| Daniel Wilson | RSU | 4,028 | — | 714,728 |
| Quentin Blackford | RSU | 23,203 | — | 4,117,140 |
| Quentin Blackford | RSU | 14,387 | — | 2,552,829 |
| Patrick Murphy | RSU | 13,589 | — | 2,411,291 |
| Chad Patterson | RSU | 13,589 | — | 2,411,291 |
| Minang Turakhia | RSU | 13,589 | — | 2,411,291 |
| Chad Patterson | RSU | 12,118 | — | 2,150,218 |
| Minang Turakhia | RSU | 11,220 | — | 1,990,877 |
| Chad Patterson | RSU | 10,742 | — | 1,906,060 |
| Chad Patterson | RSU | 10,674 | — | 1,893,995 |
| Minang Turakhia | RSU | 9,883 | — | 1,753,640 |
| Patrick Murphy | RSU | 9,282 | — | 1,646,998 |
| Daniel Wilson | RSU | 5,371 | — | 953,030 |
| Minang Turakhia | RSU | 9,282 | — | 1,646,998 |
| Daniel Wilson | RSU | 8,976 | — | 1,592,701 |
| Patrick Murphy | RSU | 8,976 | — | 1,592,701 |
| Patrick Murphy | RSU | 8,593 | — | 1,524,742 |
| Chad Patterson | RSU | 8,056 | — | 1,429,457 |
| Minang Turakhia | RSU | 7,412 | — | 1,315,185 |
| Patrick Murphy | RSU | 6,444 | — | 1,143,423 |
| Daniel Wilson | RSU | 5,801 | — | 1,029,329 |
| Chad Patterson | RSU | 5,336 | — | 946,820 |
| Patrick Murphy | RSU | 4,640 | — | 823,322 |
| Daniel Wilson | RSU | 4,275 | — | 758,556 |
| Minang Turakhia | RSU | 4,640 | — | 823,322 |
| Daniel Wilson | RSU | 2,900 | — | 514,576 |
| Minang Turakhia | RSU | 2,781 | — | 493,461 |
| Patrick Murphy | RSU | 1,504 | — | 266,870 |
| Daniel Wilson | RSU | 1,003 | — | 177,972 |
iRhythm's executive compensation programs are designed to retain and motivate a strong, capable, high functioning and experienced executive team with the ability to execute on our strategic growth objectives, while aligning strong performance, collaboration and accountability with business results and the interests of our stockholders. A substantial portion of the NEOs’ target total direct compensation is performance-based and “at-risk,” linked to corporate and stock performance.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon and Mercer |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-27 | 26,185,232 | 421,655 | 748,553 | 95.72% | Passed |
| 2025 | 2025-05-28 | 27,454,502 | 382,813 | 774,141 | 95.96% | Passed |
| 2024 | 2024-05-29 | 13,811,197 | 14,494,735 | 31,409 | 48.74% | Failed |
| 2023 | 2023-05-24 | 24,771,355 | 2,982,847 | 16,163 | 89.2% | Passed |
| 2022 | 2022-05-26 | 22,587,421 | 4,210,823 | 15,661 | 84.24% | Passed |
| 2021 | 2021-06-18 | 22,178,635 | 3,021,797 | 40,681 | 87.87% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-27 | 95.72%a |
| 2025 | 2025-05-28 | 95.96%b |
| 2024 | 2024-05-29 | 48.74%c |
a. Approved under the standard stated in the filing — “Abstentions are considered votes present and entitled to vote on this proposal, and thus, will have the same effect as a vote "against" the proposal.”.
b. Approved under the standard stated in the filing — “Abstentions are considered votes present and entitled to vote on this proposal, and thus, will have the same effect as a vote "against" the proposal.”.
c. Approved under the standard stated in the filing — “Abstentions are considered votes present and entitled to vote on this proposal, and thus, will have the same effect as a vote "against" the proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 96.6 : 1 |
|---|---|
| CEO total compensation | $11,003,163 |
| Median employee compensation | $113,889 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Kevin O'BoyleIndependent · Audit · Partial-year service · Newly elected | $33,859 | $283,313 | $0 | — | — | $317,172 |
| Karen McGinnisIndependent · Audit · Partial-year service · Newly elected | 31,440 | 283,313 | 0 | — | — | 314,753 |
| Abhijit TalwalkarIndependent · Board Chair · Compensation and Human Capital Management · Nominating and Corporate Governance | 117,500 | 191,980 | 13,606 | — | — | 309,480 |
| Brian YoorIndependent · Audit (Chair) | 80,000 | 191,980 | 0 | — | — | 271,980 |
| Bruce BodakenIndependent · Compensation and Human Capital Management · Nominating and Corporate Governance | 77,500 | 191,980 | 228 | — | — | 269,480 |
| Karen LingIndependent · Compensation and Human Capital Management (Chair) | 70,000 | 191,980 | 0 | — | — | 261,980 |
| C. Noel Bairey MerzIndependent · Compensation and Human Capital Management | 62,500 | 191,980 | 0 | — | — | 254,480 |
| Mark RubashIndependent · Nominating/Governance · Departed during FY | 36,141 | 191,980 | — | — | — | 228,121 |
| Ralph SnydermanIndependent · Departed during FY | 33,560 | 191,980 | — | — | — | 225,540 |
| Mojdeh PoulIndependent · Not standing for re-election · Departed during FY | 26,429 | 0 | — | — | — | 26,429 |
| Jason PattenIndependent · Audit · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Quentin BlackfordEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $55,000 |
|---|---|
| Annual equity retainer | $185,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 15,000 / 15,000 |
| Stock ownership guideline | $165,000 |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $568,929 |
| Equity awards (grant-date value) | $1,910,486 |
| All other compensation | $0 |
| Total cost of the board | $2,479,415 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies iRhythm Holdings, Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including iRhythm Holdings, Inc..
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Element | 2025 | Benjamin H. Gliklich | $1,087,500 | $23,688,894 | $0 | $1,520,947 | $26,480,462 |
| 2 | Masimo Corporation | 2025 | Catherine Szyman | 850,048 | 16,388,693 | 1,399,998 | 1,130,000 | 19,797,140 |
| 3 | Insulet Corporation | 2025 | Ashley McEvoy | 729,808 | 12,958,850 | 2,999,913 | 2,031,562 | 18,858,968 |
| 4 | ResMed, Inc | 2026 | Michael Farrell | 1,272,895 | 9,749,468 | 3,249,907 | 1,738,857 | 16,201,649 |
| 5 | Natera Inc. | 2025 | Steven Chapman | 853,710 | 12,979,558 | 0 | 1,114,151 | 14,957,319 |
| 6 | iRhythm Holdings, Inc. | 2025 | Quentin Blackford | 700,003 | 8,919,457 | 0 | 1,350,000 | 11,003,163 |
| 7 | Alphatec | 2025 | Patrick Miles | 762,000 | 8,859,650 | 0 | 600,000 | 10,260,507 |
| 8 | Integra LifeSciences | 2025 | Mojdeh Poul | 1,009,616 | 5,219,868 | 2,250,011 | 174,563 | 9,375,551 |
| 9 | AtriCure, Inc. | 2025 | Michael Carrel | 828,439 | 7,203,478 | 0 | 1,171,703 | 9,217,620 |
| 10 | LivaNova PLC | 2025 | Vladimir Makatsaria | 956,115 | 4,303,092 | 1,374,999 | 1,287,656 | 8,047,217 |
| 11 | Inspire Medical Systems, Inc. | 2025 | Timothy Herbert | 750,572 | 5,999,655 | 0 | 961,557 | 7,711,784 |
| 12 | Tandem Diabetes Care, Inc. | 2025 | John Sheridan | 790,583 | 5,367,796 | 0 | 674,090 | 6,858,503 |
| 13 | Fulgent Genetics, Inc. | 2025 | Ming Hsieh | 1,000,000 | 4,000,000 | 0 | 1,207,000 | 6,207,000 |
| 14 | Globus Medical, Inc. | 2025 | Keith Pfeil | 479,467 | 0 | 2,982,347 | 783,000 | 4,400,159 |
| 15 | Tactile Systems Technology | 2025 | Sheri Dodd | 675,000 | 2,019,978 | 0 | 737,438 | 3,466,916 |
| 16 | Lantheus Holdings, Inc. | 2025 | Mary Anne Heino | 100,000 | 749,963 | 749,999 | 0 | 2,173,930 |
| 17 | Penumbra, Inc. | 2025 | Adam Elsesser | 850,000 | 0 | 0 | 0 | 851,621 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| iRhythm Holdings, Inc. | 173% | RSU 50 · PSU 50 | Yes — Relative TSR | Aon and Mercer |
| Alphatec | 157% | PSU 50 · RSU 50 | No | Compensia |
| AtriCure, Inc. | 141% | PSU 70 · RSU 30 | No | Korn Ferry |
| Element | 126% | PSU 67 · RSU 33 | No | FW Cook |
| Fulgent Genetics, Inc. | 120.7% | PSU 60 · RSU 40 | No | USI |
| Globus Medical, Inc. | 102% | Options 100 | not disclosed | FW Cook |
| Inspire Medical Systems, Inc. | 111.4% | PSU 50 · RSU 50 | No | Aon |
| Insulet Corporation | 195.8% | PSU 60 · RSU 20 · Options 20 | No | Pearl Meyer & Partners, LLC |
| Integra LifeSciences | 40% | PSU 50 · Options 25 · RSU 25 | No | WTW |
| Lantheus Holdings, Inc. | 47% | PSU 50 · RSU 25 · Options 25 | Yes — relative Total Shareholder Return (rTSR) against the S&P 400 Health Care Index | Pearl Meyer |
| LivaNova PLC | 122.4% | PSU 50 · RSU 25 · Options 25 | No | Pearl Meyer |
| Masimo Corporation | not disclosed | not disclosed | not disclosed | FW Cook |
| Natera Inc. | 131.1% | PSU 50 · RSU 50 | No | Aon |
| Penumbra, Inc. | not disclosed | not disclosed | No | Compensia |
| ResMed, Inc | not disclosed | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | FW Cook |
| Tactile Systems Technology | 115% | PSU 50 · RSU 50 | No | Aon Consulting, Inc. |
| Tandem Diabetes Care, Inc. | 87% | PSU 50 · RSU 50 | Yes — TSR performance compared to the Russell 3000 index in the three-year period between 2025 and 2027 | WTW |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Quentin Blackford | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Summary Compensation Table” · page 76. As printed: 11,003,163. Filing ↗machine: r2 · c21 · span 1123498–1123508 |
| 2 | Section 01, Chad Patterson | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Summary Compensation Table” · page 76. As printed: 4,079,637. Filing ↗machine: r10 · c21 · span 1139071–1139080 |
| 3 | Section 01, Minang Turakhia | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Summary Compensation Table” · page 76. As printed: 3,625,803. Filing ↗machine: r13 · c21 · span 1145157–1145166 |
| 4 | Section 01, Patrick Murphy | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Summary Compensation Table” · page 76. As printed: 3,061,517. Filing ↗machine: r7 · c21 · span 1133382–1133391 |
| 5 | Section 01, Daniel Wilson | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Summary Compensation Table” · page 76. As printed: 3,044,373. Filing ↗machine: r5 · c21 · span 1129368–1129377 |
| 6 | Section 03, Chad Patterson RSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r4 · c2 · span 984343–984349 |
| 7 | Section 03, Chad Patterson PSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r4 · c2 · span 984343–984349 |
| 8 | Section 03, Daniel Wilson RSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r3 · c2 · span 982833–982838 |
| 9 | Section 03, Quentin Blackford PSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r2 · c2 · span 981322–981328 |
| 10 | Section 03, Quentin Blackford RSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r2 · c2 · span 981322–981328 |
| 11 | Section 03, Daniel Wilson PSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r3 · c2 · span 982833–982838 |
| 12 | Section 03, Patrick Murphy PSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r5 · c2 · span 985855–985860 |
| 13 | Section 03, Patrick Murphy RSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t185 · r5 · c2 · span 985855–985860 |
| 14 | Section 03, Minang Turakhia M.S. PSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: span 1205340–1205349 |
| 15 | Section 03, Minang Turakhia M.S. RSU | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: span 1208631–1208640 |
| 16 | Section 07, pay ratio | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “CEO Pay Ratio”. As printed: 96.6 : 1. Filing ↗machine: span 1104666–1104670 |
| 17 | Section 08, Kevin O'Boyle | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 317,172. Filing ↗machine: span 458939–459060 |
| 18 | Section 08, Karen McGinnis | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 314,753. Filing ↗machine: span 457649–457770 |
| 19 | Section 08, Abhijit Talwalkar | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 309,480. Filing ↗machine: span 453243–453364 |
| 20 | Section 08, Brian Yoor | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 271,980. Filing ↗machine: span 463838–463959 |
| 21 | Section 08, Bruce Bodaken | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 269,480. Filing ↗machine: span 455359–455480 |
| 22 | Section 08, Karen Ling | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 261,980. Filing ↗machine: span 456458–456579 |
| 23 | Section 08, C. Noel Bairey Merz | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 254,480. Filing ↗machine: span 454357–454478 |
| 24 | Section 08, Mark Rubash | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 228,121. Filing ↗machine: span 460127–460248 |
| 25 | Section 08, Ralph Snyderman | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 225,540. Filing ↗machine: span 461425–461546 |
| 26 | Section 08, Mojdeh Poul | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 26,429. Filing ↗machine: span 462612–462732 |
| 27 | Section 08, Jason Patten | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 28 | Section 08, Quentin Blackford | DEF 14A | 2026-04-17 | 0001388658-26-000030 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 29 | Section 02, Brian Lee Lawrence 2026-05-04 | Form 4 | 2026-05-05 | 0001506228-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Abhijit Talwalkar 2026-05-11 | Form 4 | 2026-05-12 | 0001316065-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Abhijit Talwalkar 2026-05-11 | Form 4 | 2026-05-12 | 0001316065-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Abhijit Talwalkar 2026-05-11 | Form 4 | 2026-05-12 | 0001316065-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Abhijit Talwalkar 2026-05-11 | Form 4 | 2026-05-12 | 0001316065-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Abhijit Talwalkar 2026-05-11 | Form 4 | 2026-05-12 | 0001316065-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Abhijit Talwalkar 2026-05-11 | Form 4 | 2026-05-12 | 0001316065-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Abhijit Talwalkar 2026-05-11 | Form 4 | 2026-05-12 | 0001316065-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Brian Yoor 2026-05-27 | Form 4 | 2026-05-29 | 0001643528-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Karen Ling 2026-05-27 | Form 4 | 2026-05-29 | 0001597450-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Bruce Bodaken 2026-05-27 | Form 4 | 2026-05-29 | 0001527009-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Kevin C. Oboyle 2026-05-27 | Form 4 | 2026-05-29 | 0001203567-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Karen McGinnis 2026-05-27 | Form 4 | 2026-05-29 | 0001188264-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Abhijit Talwalkar 2026-05-27 | Form 4 | 2026-05-29 | 0001316065-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Bairey Merz Cathleen Noel 2026-05-27 | Form 4 | 2026-05-29 | 0001738783-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Sean Clinton Freeman 2026-05-29 | Form 4 | 2026-06-01 | 0002074661-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Minang Turakhia 2026-05-29 | Form 4 | 2026-06-01 | 0001932682-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Marc Wade Rosenbaum 2026-05-29 | Form 4 | 2026-06-03 | 0001929535-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Sumi Shrishrimal 2026-05-29 | Form 4 | 2026-06-03 | 0001850687-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Chad Patterson 2026-05-29 | Form 4 | 2026-06-01 | 0001850152-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Quentin Blackford 2026-05-29 | Form 4 | 2026-06-01 | 0001612451-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Sumi Shrishrimal 2026-06-02 | Form 4 | 2026-06-03 | 0001850687-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Marc Wade Rosenbaum 2026-06-02 | Form 4 | 2026-06-03 | 0001929535-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Sean Clinton Freeman 2026-07-02 | Form 4 | 2026-07-06 | 0002074661-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Minang Turakhia 2026-07-02 | Form 4 | 2026-07-06 | 0001932682-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Julianne Rodda 2026-08-03 | Form 4 | 2026-08-04 | 0002125725-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Mervin Smith 2026-08-03 | Form 4 | 2026-08-04 | 0001985217-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Chad Patterson 2026-08-03 | Form 4 | 2026-08-04 | 0001850152-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Quentin Blackford 2026-08-07 | Form 4 | 2026-08-11 | 0001612451-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Minang Turakhia 2026-08-07 | Form 4 | 2026-08-11 | 0001932682-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Sumi Shrishrimal 2026-08-07 | Form 4 | 2026-08-11 | 0001850687-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Patrick Murphy 2026-08-07 | Form 4 | 2026-08-11 | 0001692785-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Chad Patterson 2026-08-07 | Form 4 | 2026-08-11 | 0001850152-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Patrick Murphy 2026-08-10 | Form 4 | 2026-08-11 | 0001692785-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Quentin Blackford 2026-08-10 | Form 4 | 2026-08-11 | 0001612451-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Chad Patterson 2026-08-10 | Form 4 | 2026-08-11 | 0001850152-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Minang Turakhia 2026-08-10 | Form 4 | 2026-08-11 | 0001932682-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Sumi Shrishrimal 2026-08-10 | Form 4 | 2026-08-11 | 0001850687-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Daniel Wilson 2026-09-02 | Form 4 | 2026-09-03 | 0001860745-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 06, 2026 vote | Form 8-K | 2026-05-28 | 0001388658-26-000049 | Item 5.07 · say-on-pay result. As reported: 95.72% (votes for as printed: 26,185,232). Filing ↗ |
| 69 | Section 06, 2025 vote | Form 8-K | 2025-05-30 | 0001388658-25-000141 | Item 5.07 · say-on-pay result. As reported: 95.96% (votes for as printed: 27,454,502). Filing ↗ |
| 70 | Section 06, 2024 vote | Form 8-K | 2024-05-31 | 0001388658-24-000106 | Item 5.07 · say-on-pay result. As reported: 48.74% (votes for as printed: 13,811,197). Filing ↗ |
| 71 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 72 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 73 | Section 09b board cost (computed) | Computed | — | — | Cash 568,929 + equity 1,910,486 + all other 0 = 2,479,415, summed across the director compensation table rows.machine: formula: Σ = 2,479,415 |
| 74 | Element, Section 10b CEO total | DEF 14A | 2026-03-23 | 0001590714-26-000034 | CEO total compensation as printed in Element's own proxy. As printed: 26,480,462. Filing ↗machine: r3 · c27 · span 596335–596345 |
| 75 | Masimo Corporation, Section 10b CEO total | 10-K | 2026-05-01 | 0001104659-26-054180 | CEO total compensation as printed in Masimo Corporation's own proxy. As printed: 19,797,140. Filing ↗machine: r4 · c22 · span 477159–477169 |
| 76 | Insulet Corporation, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013333 | CEO total compensation as printed in Insulet Corporation's own proxy. As printed: 18,858,968. Filing ↗machine: t218 · r3 · c25 · span 1028076–1028087 |
| 77 | ResMed, Inc, Section 10b CEO total | DEF 14A | 2026-10-01 | 0000943819-26-000080 | CEO total compensation as printed in ResMed, Inc's own proxy. As printed: 16,201,649. Filing ↗machine: span 1267106–1267116 |
| 78 | Natera Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001104659-26-047770 | CEO total compensation as printed in Natera Inc.'s own proxy. As printed: 14,957,319. Filing ↗machine: t190 · r5 · c14 · span 1269868–1269878 |
| 79 | iRhythm Holdings, Inc. (subject), Section 10b CEO total | DEF 14A | 2026-04-17 | 0001388658-26-000030 | CEO total compensation as printed in iRhythm Holdings, Inc.'s own proxy. As printed: 11,003,163. Filing ↗machine: r2 · c21 · span 1123498–1123508 |
| 80 | Alphatec, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001193125-26-191867 | CEO total compensation as printed in Alphatec's own proxy. As printed: 10,260,507. Filing ↗machine: t26 · r2 · c25 · span 858148–858158 |
| 81 | Integra LifeSciences, Section 10b CEO total | DEF 14A | 2026-04-06 | 0000917520-26-000015 | CEO total compensation as printed in Integra LifeSciences's own proxy. As printed: 9,375,551. Filing ↗machine: r2 · c30 · span 880204–880213 |
| 82 | AtriCure, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001323885-26-000010 | CEO total compensation as printed in AtriCure, Inc.'s own proxy. As printed: 9,217,620. Filing ↗machine: span 743364–743373 |
| 83 | LivaNova PLC, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001104659-26-050937 | CEO total compensation as printed in LivaNova PLC's own proxy. As printed: 8,047,217. Filing ↗machine: t117 · r3 · c50 · span 1095329–1095338 |
| 84 | Inspire Medical Systems, Inc., Section 10b CEO total | DEF 14A | 2026-03-20 | 0001140361-26-010490 | CEO total compensation as printed in Inspire Medical Systems, Inc.'s own proxy. As printed: 7,711,784. Filing ↗machine: r2 · c25 · span 1164868–1164877 |
| 85 | Tandem Diabetes Care, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001438133-26-000034 | CEO total compensation as printed in Tandem Diabetes Care, Inc.'s own proxy. As printed: 6,858,503. Filing ↗machine: r3 · c27 · span 866963–866972 |
| 86 | Fulgent Genetics, Inc., Section 10b CEO total | DEF 14A | 2026-03-31 | 0001674930-26-000020 | CEO total compensation as printed in Fulgent Genetics, Inc.'s own proxy. As printed: 6,207,000. Filing ↗machine: r3 · c22 · span 533279–533288 |
| 87 | Globus Medical, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001628280-26-027196 | CEO total compensation as printed in Globus Medical, Inc.'s own proxy. As printed: 4,400,159. Filing ↗machine: r5 · c21 · span 344690–344699 |
| 88 | Tactile Systems Technology, Section 10b CEO total | DEF 14A | 2026-03-25 | 0001104659-26-034206 | CEO total compensation as printed in Tactile Systems Technology's own proxy. As printed: 3,466,916. Filing ↗machine: r3 · c12 · span 865797–865806 |
| 89 | Lantheus Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-03-20 | 0001193125-26-117649 | CEO total compensation as printed in Lantheus Holdings, Inc.'s own proxy. As printed: 2,173,930. Filing ↗machine: r3 · c39 · span 957618–957628 |
| 90 | Penumbra, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001321732-26-000010 | CEO total compensation as printed in Penumbra, Inc.'s own proxy. As printed: 851,621. Filing ↗machine: span 424797–424804 |
| 91 | Section 10a, Insulet Corporation reciprocity | DEF 14A | — | 0001140361-26-013333 | Insulet Corporation's most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 92 | Section 10a, Penumbra, Inc. reciprocity | DEF 14A | — | 0001321732-26-000010 | Penumbra, Inc. names iRhythm Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 93 | Section 10a, Tactile Systems Technology reciprocity | DEF 14A | — | 0001104659-26-034206 | Tactile Systems Technology names iRhythm Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 94 | Section 10a, Element reciprocity | DEF 14A | — | 0001590714-26-000034 | Element's most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 95 | Section 10a, AtriCure, Inc. reciprocity | DEF 14A | — | 0001323885-26-000010 | AtriCure, Inc. names iRhythm Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 96 | Section 10a, Masimo Corporation reciprocity | DEF 14A | — | 0001104659-26-054180 | Masimo Corporation's most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 97 | Section 10a, ResMed, Inc reciprocity | DEF 14A | — | 0000943819-26-000080 | ResMed, Inc's most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 98 | Section 10a, Inspire Medical Systems, Inc. reciprocity | DEF 14A | — | 0001140361-26-010490 | Inspire Medical Systems, Inc. names iRhythm Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 99 | Section 10a, Integra LifeSciences reciprocity | DEF 14A | — | 0000917520-26-000015 | Integra LifeSciences's most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 100 | Section 10a, Alphatec reciprocity | DEF 14A | — | 0001193125-26-191867 | Alphatec names iRhythm Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 101 | Section 10a, Fulgent Genetics, Inc. reciprocity | DEF 14A | — | 0001674930-26-000020 | Fulgent Genetics, Inc.'s most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 102 | Section 10a, LivaNova PLC reciprocity | DEF 14A | — | 0001104659-26-050937 | LivaNova PLC's most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 103 | Section 10a, Natera Inc. reciprocity | DEF 14A | — | 0001104659-26-047770 | Natera Inc.'s most recent proxy was read; its disclosed peer group does not include iRhythm Holdings, Inc.. Filing ↗ |
| 104 | Section 10a, Tandem Diabetes Care, Inc. reciprocity | DEF 14A | — | 0001438133-26-000034 | Tandem Diabetes Care, Inc. names iRhythm Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the iRhythm Holdings, Inc. Executive Compensation Report
$1,500